HL-21

Overview: 

Imatinib repurposing for sickle cell anemia


Status: 


Purdue Faculty: 

Dr. Philip Low


Clinical Trial Information: 

Imatinib for Pain in Sickle Cell Anemia (IMPACT)


Development Partner: 

HuLow Medical